-
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
Overcoming Barriers to LGBTQ-inclusive Survivorship CareTransgender and bisexual cancer survivors often face more obstacles to health care than lesbians and gay men.
by Tyler Santora
-
Why Don’t More People With Cancer Enroll in Clinical Trials?Study links financial challenges with lower participation in cancer research, but some programs are working to provide easier access to information and care at local clinics.
by Dawn Fallik
-
Can People With Oral Lesions Avoid Surgery?Injecting immunotherapy directly into precancerous lesions in the mouth can shrink precancerous lesions.
by Eric Fitzsimmons
-
Wildfire Smoke Exposure Linked to Increased Cancer RiskPeople exposed to high levels of airborne particles from wildfire smoke were more likely to be diagnosed with five cancer types.
by Eric Fitzsimmons
-
Plant-forward Diet Linked to Lower Risk for Aggressive Breast Cancer SubtypeWomen who ate a diet focused on both human health and sustainability had reduced risk for estrogen receptor-negative disease.
by Thomas Celona
-
CAR T-cell Therapy Prevents Progression in High-risk Smoldering MyelomaEarly study suggests an immunotherapy can eliminate precancerous cells in people with high-risk disease.
by Darlene Dobkowski
-
Aromatase Inhibitor Use Linked to Blood Pressure, Diabetes RiskPeople who took aromatase inhibitors to prevent breast cancer recurrence for at least five years had a higher risk of developing cardiometabolic conditions.
by Eric Fitzsimmons
-
Hypothyroidism Is Associated With Increased Survival in Some CancersSome cancer survivors develop hypothyroidism as a result of cancer treatment. Research shows this side effect is linked to prolonged survival in some cancer types.
by Darlene Dobkowski
-
Forward Look
Targeted Therapy Prompts Responses in KRAS-mutated Lung CancerAn experimental KRAS inhibitor controls lung cancer after other targeted treatments stop working.
by Eric Fitzsimmons
A recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
